IL2RA and autoimmune disease: These findings, together with data we previously obtained in vitro and vivo [23], and with the solid proof-of-concept acquired in the past decades on imaging IL2R, strongly support the use of 68Ga-THP-desIL2 for the identification and quantitation of CD25+ lymphocytes in tumors and in autoimmune diseases [26,27,28,29].